Further studies revealed that after MDSCs metastasized to the tumor, their exposure to the inflammatory and hypoxic tumor microenvironment clearly resulted in Arg1 and inducible nitric oxide synthase (iNOS) and decreased ROS production. The gene discussed is ARG1; the disease is neoplasm.